| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.07 |